Cargando…
p16 mutations/deletions are not frequent events in prostate cancer.
Cyclin-dependent kinase-4 inhibitor gene (p16INK4) has recently been mapped to chromosome 9p21. Homozygous deletions of this gene have been found at high frequency in cell lines derived from different types of tumours. These findings suggested therefore, that p16INK4 is a tumour-suppressor gene invo...
Autores principales: | Tamimi, Y., Bringuier, P. P., Smit, F., van Bokhoven, A., Debruyne, F. M., Schalken, J. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074596/ https://www.ncbi.nlm.nih.gov/pubmed/8679444 |
Ejemplares similares
-
p53 mutations have no additional prognostic value over stage in bladder cancer.
por: Vet, J. A., et al.
Publicado: (1994) -
A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization.
por: Tamimi, Y., et al.
Publicado: (1996) -
Primary Malignant Lymphoma of the Brain: Demonstration of Frequent p16 and p15 Gene Deletions
por: Kumanishi, Toshiro, et al.
Publicado: (1996) -
Absence of deletions but frequent loss of expression of p16INK4 in human ovarian tumours.
por: Marchini, S., et al.
Publicado: (1997) -
Chromosome band 16q24 is frequently deleted in human gastric cancer
por: Mori, Y, et al.
Publicado: (1999)